ArticleJMA journal2025

Clinical Factors Associated with Body-weight Reduction Induced by Semaglutide 1.0 mg Weekly in Patients with Type 2 Diabetes Mellitus.

Noboru Kurinami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.